This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

VIVUS Launches Mobile App To Help Patients Lose Weight

MOUNTAIN VIEW, Calif., March 7, 2013 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) announced today the launch of the Q and Me™ app, a no-cost mobile app available through iTunes and Google Play Store designed to help patients meet their weight loss goals.  Q and Me can be used by anyone wanting to develop skills that can lead to lasting weight loss.

The Q and Me Patient Support Program ( www.QandMEsupport.com) is designed to guide patients in incorporating proper nutrition and physical activity into everyday life.  The program provides patients the ability to:
  • Set personal weight loss and fitness goals
  • Track weight, food intake/calories and physical activities/calories burned
  • Receive personalized emails providing motivation and tips
  • Access easy-to-prepare recipe suggestions

The new Q and Me app for Apple and Android-based devices now allows users to access important tools while on the go:  Food Log, Activity Log, and BMI Calculator.

"VIVUS is committed to supporting healthcare providers and patients in their treatment of obesity," said Michael P. Miller, senior vice president and chief commercial officer of VIVUS.  "The Q and Me app can help make the weight loss journey more manageable by empowering people to make changes that may lead to meaningful weight loss."

About Qsymia ®

Qsymia is approved in the U.S. and is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m 2 or greater (obese) or 27 kg/m 2 or greater (overweight) in the presence of at least one weight-related medical condition such as high blood pressure, type 2 diabetes, or high cholesterol.

The effect of Qsymia on cardiovascular morbidity and mortality has not been established. The safety and effectiveness of Qsymia in combination with other products intended for weight loss, including prescription and over-the-counter drugs, and herbal preparations, have not been established.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs